MDR-TB bavSvebSi tfdec -is bavSvTa ganyofilebis monacemTa analizi

1. MDR-TB bavSvebSitfdec-is bavSvTaganyofilebismonacemTaanalizi iaurTqmeliZe; “samSabaToba” 11.01.11

2. 2009 welssaqrTveloSi “0-15” asakobrivjgufSituberkulozidafiqsirda 287 SemTxvevaSi, maTgan • 43 filtvisTB; • 244 filtvgareSeTB iyo; • 2009 welsmgb(+) TB SemTxvevebTankontaqtisgamogamokvlevaCautardasul 3441 adamians, maTgan • 300 “0-5” asakobrivijgufisbavSviiyo; • aqtiuriTBdadasturda 17 SemTxvevaSi; • LTBI dadasturdadaCatarda IPT 165 SemTxvevaSi;

3. saqarTvelostuberkulozTanbrZoliserovnuliprogramisfarglebSibavSvTaMDR-TB-is marTva 2008 wlisagvistodanmimdinareobs; • konsiliumisgadawyvetilebiTDOTS+ programaSisulCarTulia 43 MDR-TB bavSvi; • tfdec-is bavSvTaganyofilebaSi 2008 wlisagvistodandRemdegatarebulia 466 pacienti, maTgan: • 406-Tan dadasturdaaqtiuriTB; • 41 (10%) –ma MDR-TBpacientmamkurnalobadaiwyostacionarSi;

4. statistikuraddamuSavda 2008 wlisagvistodandRemdeDOTS+ programaSiintegrirebuli 41 MDR-TB pacientismonacemi 26 monacemebimxolodraodenobrivianalizissaSualebasgvaZlevs, monacemTasimcirisgamocvladebsSorisasocirebuli, an pirdapirikavSirisdadgenavermoxerxda 13

5. 37 35

6. BCG-rebulibavSvebidankeloidiaretyoba 4-s maTgan 2 “0-3”, xolo 2 “15-18” asakobrivjgufsmiekuTvneba; • rvavearaBCG-rebulTanMDR-TBkontaqtisSedegadganviTarda;

7. 24

8. 15

9. masalisCabarebavermoxerxda 41-dan mxolod 5 SemTxvevaSi; mgb(+) iyo 25%; kultura(+) 52.8%. 27 19

14. gverdiTimovlenebiganviTarda 14 (34%) pacientTan; preparatiSewyda 4 (9.76%) SemTxvevaSi 9(64.3%) gverdiTimovlenebisganviTarebisSemTxvevebidanmkurnalobisgamosavaligvaqvs 5 pacientTan; arcerTTanmkurnalobisSewyvetagverdiTimovlenisgamoarmomxdara

15. 9 mgb(+) SemTxvevidannaxveliskonversia7pacientTanstacionarSimkurnalobisperiodSimkurnalobisdawyebidan 0-2 TveSidafiqsirda; • 19 kultura (+) SemTxvevidan12-Tan kulturiskonversiastacionarSimkurnalobisperiodSidafiqsirda; maTgan 11 pacientTan 0-2 TveSi, 1 pacientTan 2-5 TvisperiodSi;

16. stacionarulimkurnalobisperiodSiSemTxvevaTaumravlesobaSi (95.1% da 90.2%) dafiqsirdadadebiTiklinikuridarentgenologiuridinamika

17. mkurnalobisgamosavalidafiqsirebulia18 MDR-TB bavSvTan

18. MDR-TB bavSvebismkurnalobisgamosavaliasakobrivijgufebismixedviT 7 8

19. daskvna: • bavSvebSiMDR-TB-is ganviTarebismTavaririskiojaxuriTB kontaqtia; • saqarTveloSiuzrunvelyofiliasrulyofiliBCG-reba; • tep-is farglebSimantussinjiTdiagnostirebayvelasTvisxelmisawvdomia; • iseverogorczogadadmsoflioSiCveniqveynismagaliTzecbavSvebiupiratesadfiltvgareSeTB-iTavaddebian; • sirTuleebismiuxedavadtfdec-is farglebSimaqsimaluradgrovdebapaTologiurimasala, TumcaverxerxdebakuWisaspiratisgamokvlevaracmniSvnelovnadgaaumjobesebdadiagnostikas; • CvensmagaliTzemaRaliakultura(+) SemTxvevebisdaSesabamisadDOTS+ programaSisakuTarDST-zedayrdnobiTCarTvismaCvenebeli [19 (46.3%)];

20. CvensmagaliTzemaRaliararisgverdiTimovlenebisganviTarebis [14 (34%)] dapreparatebisSewyvetismaCvenebeli [4 (9.76%)]; • stacionarSimkurnalobisperiodSimaqsimaluradmiiRweva: • naxvelisdakulturiskonversia; • klinikuridarentgenologiuridadebiTidinamika; • samwuxarodgvaqvsgardacvalebisdaSewyvetilimkurnalobisSemTxvevebi; • SewyvetilimkurnalobisarcerTSemTxvevaSiwyvetismizezadgverdiTimovlenaardafiqsirebula, racbavSvTaTB-Si mkurnalobisadmidamyolobisproblemazemiuTiTebs;

21. gmadlobTyuradRebisTvis